Advertisement
Subscribe now
Log in
May 18, 2026 17:19
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Media OutReach Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Your Consultant
KPMG
PwC
Indochine Counsel
Vilasia
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
Swing for the Kids
CSR
World News
Tags
Ottimo Pharma
Lotte Biologics expands antibody manufacturing agreement with Ottimo Pharma
May 18, 2026 | 15:33
The South Korean firm announced on 18 May 2026 an expanded collaboration to produce PD-1/VEGFR2 dual-paratopic antibodies, reinforcing its strategic partnership.
Latest News
Minish Veneers USA concludes biomimetic veneers course at Vita North America
Daesang to showcase its global food leadership at Thaifex-Anuga Asia 2026
BenQ delivers a complete meeting room solution with new board and wireless system
Lotte Biologics expands antibody manufacturing agreement with Ottimo Pharma
Mobile Version